Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Finances

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton May 05, 2023 12:51pm

216 Views

Post# 35433302

RE:RE:Finances

I vote for a JV. It would be a terrible shame to have a buyout at this stage of the game, when there is so much unexploited IP waiting in the wings. It's certainly not in shareholders' interest for Theralase to be bought out for a small fraction of it's value. And Roger Dumoulin-White is Theralase's biggest shareholder so it's not in his interest either.